The Latest Cardiac and Vascular News
PALO ALTO, Calif.–(BUSINESS WIRE)–Vista, a leader in intelligent MRI acquisition software, today announced two-year clinical results showing Vista Cardiac significantly improves workflow efficiency, ensures high-quality and consistent imaging, and scales cardiac MRI (CMR) programs to expand access to more patients. “We’re pleased with the strong data from Brigham and Women’s Hospital validating […]
Incidental CAC Scores Now Possible with ClearRead™ CT MIAMISBURG, Ohio, Dec. 3, 2024 /PRNewswire/ — Coronary artery calcification (CAC) affects 20 million Americans annually, and over half of the incidental findings go unreported.* New FDA-cleared technology from Riverain can provide a…
Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update
Join Cleerly Leadership for Live Demonstrations on Advanced Imaging Solutions for Personalized Heart Disease Care DENVER, Nov. 26, 2024 /PRNewswire/ — Cleerly, a leader in advanced cardiovascular imaging, is excited to announce its participation in the Radiological Society of North…
November 25, 2024 09:21 AM Eastern Standard Time BURLINGTON, Mass.–(BUSINESS WIRE)–BrioHealth Solutions, Inc., a developer of world-leading technology in ventricular assist systems, announced today it has enrolled its first patients in the U.S. for the INNOVATE Trial of the BrioVAD® System. BrioHealth Solutions announced today the first patients have been enrolled […]
DALLAS–(BUSINESS WIRE)–Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced the successful closing of a $20.4 million round of financing. This funding will enable Secretome to initiate clinical trials for its lead asset, STM-01, and further advance its innovative pipeline. “We are grateful […]
November 25, 2024 03:30 AM Eastern Standard Time LONDON–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): […]
Trial completion marks an important milestone in the development of the next generation, embolic protection platform MINNEAPOLIS, Nov. 21, 2024 /PRNewswire/ — Cardiovascular medical device company, EmStop, Inc., today announced the completion of the CAPTURE-1 early feasibility clinical…
Collaboration with health technology company Tempus seeks to identify causes for undertreatment of minority patients with heart valve disease who may benefit from minimally invasive therapies Medtronic plc, a global leader in healthcare technology, today announced it began a randomized study sponsored by Tempus, a technology company leading the adoption […]
EchoGo® Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an underdiagnosed cause of heart failure. EchoGo® Amyloidosis sits on Ultromics’ EchoGo® platform complementing the existing commercialized EchoGo® Heart Failure…
